Scandinavian ChemoTech Past Earnings Performance
Past criteria checks 0/6
Scandinavian ChemoTech's earnings have been declining at an average annual rate of -12.5%, while the Medical Equipment industry saw earnings growing at 22.9% annually. Revenues have been declining at an average rate of 3.3% per year.
Key information
-12.5%
Earnings growth rate
20.0%
EPS growth rate
| Medical Equipment Industry Growth | 6.2% |
| Revenue growth rate | -3.3% |
| Return on equity | -175.1% |
| Net Margin | -312.0% |
| Next Earnings Update | 04 Mar 2025 |
Recent past performance updates
Recent updates
Revenue & Expenses Breakdown
How Scandinavian ChemoTech makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Sep 24 | 5 | -16 | 16 | 0 |
| 30 Jun 24 | 5 | -17 | 16 | 0 |
| 31 Mar 24 | 4 | -19 | 19 | 0 |
| 31 Dec 23 | 3 | -21 | 19 | 0 |
| 30 Sep 23 | 3 | -22 | 28 | 0 |
| 30 Jun 23 | 2 | -23 | 26 | 0 |
| 31 Mar 23 | 0 | -23 | 18 | 0 |
| 31 Dec 22 | 0 | -23 | 18 | 0 |
| 30 Sep 22 | 0 | -22 | 18 | 0 |
| 30 Jun 22 | 0 | -22 | 16 | 0 |
| 31 Mar 22 | 2 | -20 | 17 | 0 |
| 31 Dec 21 | 3 | -18 | 17 | 0 |
| 30 Sep 21 | 3 | -15 | 12 | 0 |
| 30 Jun 21 | 3 | -12 | 11 | 0 |
| 31 Mar 21 | 2 | -11 | 11 | 0 |
| 31 Dec 20 | 1 | -12 | 10 | 0 |
| 30 Sep 20 | 2 | -14 | 15 | 0 |
| 30 Jun 20 | 2 | -14 | 15 | 0 |
| 31 Mar 20 | 4 | -13 | 15 | 0 |
| 31 Dec 19 | 5 | -12 | 15 | 0 |
| 30 Sep 19 | 5 | -10 | 11 | 0 |
| 30 Jun 19 | 6 | -9 | 11 | 0 |
| 31 Mar 19 | 5 | -9 | 12 | 0 |
| 31 Dec 18 | 5 | -8 | 12 | 0 |
| 30 Sep 18 | 4 | -6 | 4 | 0 |
| 30 Jun 18 | 4 | -6 | 5 | 0 |
| 31 Mar 18 | 3 | -7 | 7 | 0 |
| 31 Dec 17 | 2 | -8 | 9 | 0 |
| 30 Sep 17 | 2 | -10 | 11 | 0 |
| 30 Jun 17 | 2 | -8 | 10 | 0 |
| 31 Mar 17 | 2 | -6 | 8 | 0 |
| 31 Dec 16 | 2 | -4 | 5 | 0 |
| 30 Sep 16 | 1 | -2 | 3 | 0 |
| 30 Jun 16 | 1 | -1 | 2 | 0 |
| 30 Jun 15 | 0 | 0 | 0 | 0 |
Quality Earnings: CMOTEC B is currently unprofitable.
Growing Profit Margin: CMOTEC B is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: CMOTEC B is unprofitable, and losses have increased over the past 5 years at a rate of 12.5% per year.
Accelerating Growth: Unable to compare CMOTEC B's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: CMOTEC B is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (31%).
Return on Equity
High ROE: CMOTEC B has a negative Return on Equity (-175.1%), as it is currently unprofitable.